Tabassome Simon

Genetic Determinants of Response to Clopidogrel and Cardiovascular Events

Tabassome Simon, Céline Verstuyft, Murielle Mary‐Krause et al. · New England Journal of Medicine · 2008 · 1.7K citations · Full text

Medicine, Genetics, Pharmacology +17

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

Laurent Beaugerie, Nicole Brousse, Anne‐Marie Bouvier et al. · The Lancet · 2009 · 1.1K citations

Medicine, Hematology, Immunology +11

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C ^hi and Ly6C ^lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

Christophe Combadière, Stéphane Potteaux, Mathieu P. Rodero et al. · Circulation · 2008 · 647 citations

Life Sciences, Immunology, Pathobiology +17

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

Jessica L. Mega, Sandra Close, Stephen D. Wiviott et al. · The Lancet · 2010 · 612 citations

Medicine, Cardiology, Pharmacology +17

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau et al. · New England Journal of Medicine · 2018 · 611 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17